Search Results - "Hector Lucas Luciardi"

Risk of developing Type 2 Diabetes Mellitus in a vulnerable community in northern Argentina by ALEMAN, Mariano Nicolás, Luciardi, María Constanza, Medina, Mariana Soledad, Pera, Mariana, Centeno Maxzud, Mirta, Luciardi, Hector Lucas

“…  Introduction: Prevention of diabetes requires sustained lifestyle changes as well as identification of groups at higher risk. Objective: The aim of this…”
Get full text

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF by Bassand, Jean-Pierre, Accetta, Gabriele, Camm, Alan John, Cools, Frank, Fitzmaurice, David A, Fox, Keith A A, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Hacke, Werner, Kayani, Gloria, Mantovani, Lorenzo G, Misselwitz, Frank, Ten Cate, Hugo, Turpie, Alexander G G, Verheugt, Freek W A, Kakkar, Ajay K

“…The relationship between outcomes and time after diagnosis for patients with non-valvular atrial fibrillation (NVAF) is poorly defined, especially beyond the…”
Get full text

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation by Camm, A John, Accetta, Gabriele, Ambrosio, Giuseppe, Atar, Dan, Bassand, Jean-Pierre, Berge, Eivind, Cools, Frank, Fitzmaurice, David A, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Kayani, Gloria, Koretsune, Yukihiro, Mantovani, Lorenzo G, Misselwitz, Frank, Oh, Seil, Turpie, Alexander G G, Verheugt, Freek W A, Kakkar, Ajay K

“…We studied evolving antithrombotic therapy patterns in patients with newly diagnosed non-valvular atrial fibrillation (AF) and ≥1 additional stroke risk factor…”
Get more information

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry by Haas, Sylvia, Ten Cate, Hugo, Accetta, Gabriele, Angchaisuksiri, Pantep, Bassand, Jean-Pierre, Camm, A John, Corbalan, Ramon, Darius, Harald, Fitzmaurice, David A, Goldhaber, Samuel Z, Goto, Shinya, Jacobson, Barry, Kayani, Gloria, Mantovani, Lorenzo G, Misselwitz, Frank, Pieper, Karen, Schellong, Sebastian M, Stepinska, Janina, Turpie, Alexander G G, van Eickels, Martin, Kakkar, Ajay K

“…Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend a target range of international normalised ratio (INR) of…”
Get full text

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation by Bassand, Jean-Pierre, Accetta, Gabriele, Al Mahmeed, Wael, Corbalan, Ramon, Eikelboom, John, Fitzmaurice, David A, Fox, Keith A A, Gao, Haiyan, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Kayani, Gloria, Pieper, Karen, Turpie, Alexander G G, van Eickels, Martin, Verheugt, Freek W A, Kakkar, Ajay K

“…The factors influencing three major outcomes-death, stroke/systemic embolism (SE), and major bleeding-have not been investigated in a large international…”
Get full text

Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation: Results From the GARFIELD-AF Registry by Bassand, Jean-Pierre, Virdone, Saverio, Goldhaber, Samuel Z, Camm, A John, Fitzmaurice, David A, Fox, Keith A.A, Goto, Shinya, Haas, Sylvia, Hacke, Werner, Kayani, Gloria, Mantovani, Lorenzo G, Misselwitz, Frank, Pieper, Karen S, Turpie, Alexander G.G, van Eickels, Martin, Verheugt, Freek W.A, Kakkar, Ajay K

“…BACKGROUND:Atrial fibrillation is associated with increased risks of death, stroke/systemic embolism, and bleeding (incurred by antithrombotic therapy), which…”
Get full text

Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF by Haas, Sylvia, Camm, A John, Bassand, Jean-Pierre, Angchaisuksiri, Pantep, Cools, Frank, Corbalan, Ramon, Gibbs, Harry, Jacobson, Barry, Koretsune, Yukihiro, Mantovani, Lorenzo G, Misselwitz, Frank, Panchenko, Elizaveta, Ragy, Hany Ibrahim, Stepinska, Janina, Turpie, Alexander GG, Sawhney, Jitendra PS, Steffel, Jan, Lim, Toon Wei, Pieper, Karen S, Virdone, Saverio, Verheugt, Freek WA, Kakkar, Ajay K

“…A principal aim of the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) was to document changes in treatment practice for patients…”
Get full text

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation by Fox, Keith A A, Lucas, Joseph E, Pieper, Karen S, Bassand, Jean-Pierre, Camm, A John, Fitzmaurice, David A, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Hacke, Werner, Kayani, Gloria, Oto, Ali, Mantovani, Lorenzo G, Misselwitz, Frank, Piccini, Jonathan P, Turpie, Alexander G G, Verheugt, Freek W A, Kakkar, Ajay K

“…ObjectivesTo provide an accurate, web-based tool for stratifying patients with atrial fibrillation to facilitate decisions on the potential benefits/risks of…”
Get full text

Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry by Verheugt, Freek W A, Gao, Haiyan, Al Mahmeed, Wael, Ambrosio, Giuseppe, Angchaisuksiri, Pantep, Atar, Dan, Bassand, Jean-Pierre, Camm, A John, Cools, Frank, Eikelboom, John, Kayani, Gloria, Lim, Toon Wei, Misselwitz, Frank, Pieper, Karen S, van Eickels, Martin, Kakkar, Ajay K

“…Abstract Aims Current atrial fibrillation (AF) guidelines discourage antiplatelet (AP) monotherapy as alternative to anticoagulants (ACs). Why AP only is still…”
Get full text

Vitamin D levels in a population from Argentina with metabolic disorders by Luciardi, Maria Constanza, Alemán, Mariano Nicolás, Martinez, Daniela, Maxzud, Mirta Centeno, Soria, Analía, Aldonati, Mirta Ester, Luciardi, Hector Lucas

“…Metabolic disorders are a public health problem worldwide. The vitamin D status in patients with metabolic diseases is not a routine procedure. The aim of this…”
Get full text

Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry by Oh, Seil, Goto, Shinya, Accetta, Gabriele, Angchaisuksiri, Pantep, Camm, A. John, Cools, Frank, Haas, Sylvia, Kayani, Gloria, Koretsune, Yukihiro, Lim, Toon Wei, Misselwitz, Frank, van Eickels, Martin, Kakkar, Ajay K

“…Abstract Objective To compare the distribution of international normalized ratios (INRs) in patients receiving vitamin K antagonist (VKA) for newly diagnosed…”
Get full text

Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF by Verheugt, Freek W.A., Ambrosio, Giuseppe, Atar, Dan, Bassand, Jean-Pierre, Camm, A. John, Costabel, Juan Pablo, Fitzmaurice, David A., Illingworth, Laura, Goldhaber, Samuel Z., Goto, Shinya, Haas, Sylvia, Jansky, Petr, Kayani, Gloria, Stepinska, Janina, Turpie, Alexander G.G., van Eickels, Martin, Kakkar, Ajay K.

“…Many patients with atrial fibrillation have concomitant coronary artery disease with or without acute coronary syndromes and are in need of additional…”
Get full text

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation by Lip, Gregory Y H, Rushton-Smith, Sophie K, Goldhaber, Samuel Z, Fitzmaurice, David A, Mantovani, Lorenzo G, Goto, Shinya, Haas, Sylvia, Bassand, Jean-Pierre, Camm, Alan John, Ambrosio, Giuseppe, Janský, Petr, Al Mahmeed, Wael, Oh, Seil, van Eickels, Martin, Raatikainen, Pekka, Steffel, Jan, Oto, Ali, Kayani, Gloria, Accetta, Gabriele, Kakkar, Ajay K

“…Among patients with atrial fibrillation (AF), women are at higher risk of stroke than men. Using prospective cohort data from a large global population of…”
Get full text

Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry by Camm, A John, Accetta, Gabriele, Al Mahmeed, Wael, Ambrosio, Giuseppe, Goldhaber, Samuel Z, Haas, Sylvia, Jansky, Petr, Kayani, Gloria, Misselwitz, Frank, Oh, Seil, Oto, Ali, Raatikainen, Pekka, Steffel, Jan, van Eickels, Martin, Kakkar, Ajay K

“…ObjectivesGlobal Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) explored the impact of gender, risk factors and anticoagulant (AC)…”
Get full text

Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry by Cools, Frank, Wollaert, Bart, Vervoort, Geert, Verstraete, Stefan, Voet, Joeri, Hermans, Kurt, Heyse, Alex, De Wolf, Axel, Hollanders, Geert, Boussy, Tim, Anné, Wim, Vercammen, Jan, Faes, Dirk, Beutels, Michel, Mairesse, Georges, Purnode, Philippe, Blankoff, Ivan, Vandergoten, Peter, Capiau, Luc, Allu, Jagan, Bassand, Jean-Pierre, Kayani, Gloria

“…Background: AF, anticoagulation, NOACs, changing patterns of prescription. Methods: We describe baseline data and treatment patterns of patients recruited in…”
Get full text

Evolving quality standards for large-scale registries: the GARFIELD-AF experience by Fox, Keith A.A., Gersh, Bernard J., Traore, Sory, John Camm, A., Kayani, Gloria, Krogh, Anders, Shweta, Shweta, Kakkar, Ajay K.

“…Aims Registries have the potential to capture treatment practices and outcomes in populations beyond the constraints of clinical trial settings. The value of…”
Get full text

Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) by Fox, Keith A A, Accetta, Gabriele, Pieper, Karen S, Bassand, Jean-Pierre, Camm, A John, Fitzmaurice, David A, Kayani, Gloria, Kakkar, Ajay K

“…Abstract Aims Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting…”
Get full text

RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial by Lopardo, Gustavo, Belloso, Waldo H., Nannini, Esteban, Colonna, Mariana, Sanguineti, Santiago, Zylberman, Vanesa, Muñoz, Luciana, Dobarro, Martín, Lebersztein, Gabriel, Farina, Javier, Vidiella, Gabriela, Bertetti, Anselmo, Crudo, Favio, Alzogaray, Maria Fernanda, Barcelona, Laura, Teijeiro, Ricardo, Lambert, Sandra, Scublinsky, Darío, Iacono, Marisa, Stanek, Vanina, Solari, Rubén, Cruz, Pablo, Casas, Marcelo Martín, Abusamra, Lorena, Luciardi, Héctor Lucas, Cremona, Alberto, Caruso, Diego, de Miguel, Bernardo, Lloret, Santiago Perez, Millán, Susana, Kilstein, Yael, Pereiro, Ana, Sued, Omar, Cahn, Pedro, Spatz, Linus, Goldbaum, Fernando

“…passive immunotherapy is a therapeutic alternative for patients with COVID-19. Equine polyclonal antibodies (EpAbs) could represent a source of scalable…”
Get full text

Estrategias de colaboración para la red de Revistas Cardiovasculares Iberoamericanas by Manlio F. Márquez, Magda Heras, María del Pilar Aguilar, Fernándo Alfonso, Kaduo Arai, Carlos Barrero, César Belzeti, Sofía Berman, Nedina Coromoto, Alejandro Cuesta, Ismael Guzmán, Bey Mario Lombana, Ricardo López Santi, Hector Lucas Luciardi, Washinton Macías, Felipe Moreira, María Paniagua, Leopoldo Pérez de Isla, Walter Reyes Caorsi, Ana Salvati

“…La necesidad de colaboración entre las diferentes revis¬tas cardiológicas de Iberoamérica es evidente. Por ello, en 2009 se conformó la Red de Revistas…”
Get full text

Determination of blood markers and inflammation in subjects with impaired glucose tolerance by Lucas-Luciardi, Héctor, Berman, Sofia G, Chain, Sergio, Feldman, Gabriela, Herrera, Ramón N, Muntaner, Juan A, del Pino, Enrique J, Martínez-Reding, Jesús, Martínez-Sánchez, Carlos R

“…This study was designed to explore the presence of a prothrombotic state, fibrinolytic dysfunction and inflammation in impaired glucose tolerance subjects, by…”
Get full text